A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT05244070 · TERMINATED
Trial details
- NCT number
- NCT05244070
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2023-05-04
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.